Literature DB >> 9824643

The invasion potentials of human biliary tract carcinoma cell lines: correlation between invasiveness and morphologic characteristics.

N Koike1, T Todoroki, T Kawamoto, S Yoshida, H Kashiwagi, K Fukao, T Ohno, T Watanabe.   

Abstract

The abilities of 9 kinds of human biliary tract carcinoma cell lines to invade through basement membrane or type I collagen were examined using an in vitro invasion assay system. The correlations between invasiveness and morphologic characteristics of the carcinoma cells in 3 dimensional collagen gel were also examined. most of the biliary tract carcinoma cell lines kept the abilities of glandular differentiation and basement membrane formation of the original tumor. Their invasiveness, however, correlated with the degree of in vitro morphologic differentiation regardless of their original morphology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824643     DOI: 10.3892/ijo.13.6.1269

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.

Authors:  Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima; Sei Shu; Nobuyuki Ishikura; Shunichi Ariizumi; Masakazu Yamamoto; Kunihiko Kurosaki; Junichi Shoda
Journal:  J Gastroenterol       Date:  2014-08-12       Impact factor: 7.527

Review 2.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

3.  Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.

Authors:  Kenichiro Onuki; Hiroaki Sugiyama; Kazunori Ishige; Toru Kawamoto; Takehiro Ota; Shunichi Ariizumi; Masayuki Yamato; Shinichi Kadota; Kaoru Takeuchi; Akiko Ishikawa; Masafumi Onodera; Kojiro Onizawa; Masakazu Yamamoto; Eiji Miyoshi; Junichi Shoda
Journal:  J Gastroenterol       Date:  2013-04-17       Impact factor: 7.527

4.  Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells.

Authors:  Moriatsu Takada; Yonson Ku; Kazuto Habara; Tetsuo Ajiki; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

5.  Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.

Authors:  Kahori Seto; Junichi Shoda; Tomohisa Horibe; Eiji Warabi; Masayuki Kohno; Toru Yanagawa; Hiroki Bukawa; Yasuni Nakanuma; Koji Kawakami
Journal:  Int J Hepatol       Date:  2014-04-27

6.  Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.

Authors:  Junichi Shoda; Atsushi Matsuda; Takashi Shida; Masakazu Yamamoto; Masato Nagino; Toshio Tsuyuguchi; Takahiro Yasaka; Susumu Tazuma; Kazuhisa Uchiyama; Michiaki Unno; Nobuaki Ohkohchi; Yasuni Nakanuma; Atsushi Kuno; Hisashi Narimatsu
Journal:  J Gastroenterol       Date:  2016-06-29       Impact factor: 7.527

7.  Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.

Authors:  Wolfgang Stremmel; Simone Staffer; Ralf Weiskirchen
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

8.  Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells.

Authors:  Hiroe Ono; Dai Chihara; Fumiko Chiwaki; Kazuyoshi Yanagihara; Hiroki Sasaki; Hiromi Sakamoto; Hideo Tanaka; Teruhiko Yoshida; Norihisa Saeki; Keitaro Matsuo
Journal:  J Carcinog       Date:  2013-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.